Debel Pharmaceuticals Private Limited
About Debel Pharmaceuticals Private Limited
Data last updated:
Debel Pharmaceuticals Private Limited is a private limited company based in Manika, Bihar, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 16 January 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U85100BR2013PTC019764. Its GSTIN is 10AAECD5613P1ZQ (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anita and Sanjeev Kumar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ram Yash Prasad Singh S/O Late Ray Shankar Prasad, Manika, Bihar, India – 843119.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.89 Lakh, a decline of 33% compared to the previous year. For the same year it recorded a net loss of ₹1,137 (net margin -0.2%) and EBITDA of ₹3,489 (EBITDA margin 0.7%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 19% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Debel Pharmaceuticals Private Limited's registered office is in Manika, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRam Yash Prasad Singh S/O Late Ray Shankar Prasad, Manika, Bihar, India – 843119
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Debel Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Debel Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Debel Pharmaceuticals Private Limited, buy the company report.
Financials of Debel Pharmaceuticals Private Limited
FY 2025 filings availableDebel Pharmaceuticals Private Limited reported revenue of ₹4.89 Lakh (down 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 33% fall in the latest year. EBITDA fell 91% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,489 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,137 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Debel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Debel Pharmaceuticals Private Limited
Debel Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anita | Director | 15 Jun 2016 | 10 Years 4 Months | Current |
| Sanjeev Kumar | Director | 16 Jan 2013 | 13 Years 9 Months | Current |
Peer comparison
Debel Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Evans Pharmaceuticals Private Limited | ₹4.94 Lakh (FY 2025) | 16.0% | Kozhikode, Kerala, India | |||
| Debel Pharmaceuticals Private Limitedthis company | ₹4.89 Lakh (FY 2025) | -₹1,137 | -0.2% | -33.0% | Manika, Bihar, India | |
| Fosto Pharmaceuticals Private Limited | ₹4.87 Lakh (FY 2025) | 44.0% | Bareilly, Uttar Pradesh, India | |||
| Affix Pharmaceuticals Private Limited | ₹4.81 Lakh (FY 2025) | -34.0% | Delhi, India |
To see the full peer comparison of Debel Pharmaceuticals Private Limited, buy the company report.
Auditor
Debel Pharmaceuticals Private Limited is audited by MANISH KUMAR CHAWARA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH KUMAR CHAWARA | FY 2017 | 128698 |
Shareholding
The shareholding of Debel Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Debel Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Debel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Debel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Debel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECD5613P1ZQ | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Debel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Debel Pharmaceuticals Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Prabhat Kumar ceased to be Director on 23 Aug 2016.
Frequently asked questions
Debel Pharmaceuticals is an active private limited company based in Manika, Bihar, India. The company works in chemical products, within the chemicals industry. It was incorporated on 16 January 2013 (13+ years old) and is registered under CIN U85100BR2013PTC019764.
Debel Pharmaceuticals has 2 current directors:
- Anita - Director
- Sanjeev Kumar - Director
The latest financial statements of Debel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Debel Pharmaceuticals is 10AAECD5613P1ZQ, registered in Bihar.
The CIN (Corporate Identification Number) of Debel Pharmaceuticals is U85100BR2013PTC019764. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Debel Pharmaceuticals was incorporated on 16 January 2013, making it 13+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Debel Pharmaceuticals by revenue are Evans Pharmaceuticals Private Limited, Fosto Pharmaceuticals Private Limited, Affix Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Prabhat Kumar ceased to be Director on 23 Aug 2016. Anita was appointed as Director on 15 Jun 2016. Ram Kumar ceased to be Director on 15 Jun 2016. Debel Pharmaceuticals has 4 board changes on record in total.
The registered office of Debel Pharmaceuticals is at Ram Yash Prasad Singh SO Late Ray Shankar Prasad, Manika, Bihar, India – 843119.
Debel Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Debel Pharmaceuticals is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.